Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
1.3.1. Drug Discovery Informatics Market, by Function, 2016-2026 (USD Million)
1.3.2. Drug Discovery Informatics Market, by Solution , 2016-2026 (USD Million)
1.3.3. Drug Discovery Informatics Market, by End-user 2016-2026 (USD Million)
1.3.4. Drug Discovery Informatics Market, by Region, 2016-2026 (USD Million)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Drug Discovery Informatics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Drug Discovery Informatics Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Drug Discovery Informatics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Drug Discovery Informatics Market, by Function
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Drug Discovery Informatics Market, Sub Segment Analysis
5.3.1. Sequencing & Target Data Analysis
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.2. Docking
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.3. Molecular Modelling
5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.4. Libraries & Database Preparation
5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
5.3.5. Other Functions
5.3.5.1. Market estimates & forecasts, 2016-2026 (USD Million)
5.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 6. Global Drug Discovery Informatics Market, by Solution
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Drug Discovery Informatics Market, Sub Segment Analysis
6.3.1. Software
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
6.3.2. Services
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 7. Global Drug Discovery Informatics Market, by End User
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Drug Discovery Informatics Market, Sub Segment Analysis
7.3.1. Pharmaceutical and Biotechnology Companies
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.2. Contract Research Organizations (CROS)
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
7.3.3. Others End Users
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
7.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 8. Global Drug Discovery Informatics Market, by Regional Analysis
8.1. Drug Discovery Informatics Market, Regional Market Snapshot (2016-2026)
8.2. North America Drug Discovery Informatics Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.2.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.2.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.2.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3. Europe Drug Discovery Informatics Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.3.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.3.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.3. Rest of Europe
8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.3.3.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.3.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.3.3.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4. Asia Drug Discovery Informatics Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.3.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.3.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.3.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.4.4.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.4.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.4.4.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5. Latin America Drug Discovery Informatics Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.5.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.5.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.5.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.6.1.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6.1.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6.1.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
8.6.2.2. Function breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6.2.3. Solution breakdown estimates & forecasts, 2016-2026 (USD Million)
8.6.2.4. End-user breakdown estimates & forecasts, 2016-2026 (USD Million)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Jubilant Life Sciences
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. IBM
9.3.3. Infosys
9.3.4. Thermo Fisher Scientific
9.3.5. Perkinelmer
9.3.6. Schr?dinger
9.3.7. Dassault Syst?mes
9.3.8. Charles River Laboratories
9.3.9. Selvita
9.3.10. GVK Biosciences
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption